CRISPR Therapeutics
CRSP
#3337
Rank
S$4.63 B
Marketcap
$54.35
Share price
-3.82%
Change (1 day)
-37.32%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -S$0.32 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are S$0.20 Billion. In 2023 the company made an earning of -S$0.21 Billion, an increase over its 2022 earnings that were of -S$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.32 Billion54.63%
2023 -S$0.21 Billion-76.83%
2022 -S$0.89 Billion-271.4%
2021 S$0.51 B-209.04%
2020 -S$0.48 Billion-617.12%
2019 S$91.45 M-140.93%
2018 -S$0.23 Billion146.86%
2017 -S$90.51 Million193.19%
2016 -S$30.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.19 Billion-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA